We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
26
PUT
Quest Diagnostics
DGX
$26.2B
$25.2M 0.82%
+184,200
New +$25.7M
ABT icon
27
PUT
Abbott
ABT
$192B
$23.1M 0.75%
195,000
-65,000
-25% -$8.06M
FXD icon
28
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$271M
$22.9M 0.74%
200,000
-46,400
-19% -$2.64M
ISRG icon
29
CALL
Intuitive Surgical
ISRG
$142B
$22.8M 0.74%
+75,500
New +$22.1M
ILMN icon
30
CALL
Illumina
ILMN
$28.9B
$22.7M 0.74%
+66,820
New +$22.6M
ATRC icon
31
AtriCure
ATRC
$2.19B
$22.1M 0.72%
336,615
-39,516
-11% -$2.56M
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$133B
$21.9M 0.71%
84,057
+59,421
+241% +$14.1M
TXG icon
33
PUT
10x Genomics
TXG
$7.4B
$21.6M 0.7%
284,400
+107,000
+60% +$9.36M
OM icon
34
Outset Medical
OM
$85.7M
$21.6M 0.7%
31,660
+1,446
+5% +$870K
TRUP icon
35
PUT
Trupanion
TRUP
$1.32B
$20.1M 0.65%
225,000
+160,600
+249% +$14.8M
SYK icon
36
PUT
Stryker
SYK
$133B
$20.1M 0.65%
75,000
-35,000
-32% -$9.06M
SLGC
37
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$19.9M 0.64%
2,475,815
-9,600
-0.4% -$84.7K
SEER icon
38
CALL
Seer Inc
SEER
$117M
$19.8M 0.64%
1,300,000
+355,600
+38% +$5.5M
GH icon
39
CALL
Guardant Health
GH
$22B
$18.2M 0.59%
275,000
+255,000
+1,275% +$17.5M
IMDX
40
Insight Molecular Diagnostics
IMDX
$141M
$18.2M 0.59%
611,198
– –
XRAY icon
41
PUT
Dentsply Sirona
XRAY
$2.26B
$18.1M 0.59%
+368,000
New +$19.5M
XNTK icon
42
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.26B
$17.9M 0.58%
199,200
+100,600
+102% +$14.3M
BSX icon
43
CALL
Boston Scientific
BSX
$74.7B
$17.7M 0.57%
+400,000
New +$17.3M
WAT icon
44
PUT
Waters Corp
WAT
$40.8B
$16.8M 0.54%
54,000
-16,300
-23% -$5.3M
ABBV icon
45
PUT
AbbVie
ABBV
$439B
$16.2M 0.53%
+100,000
New +$14.5M
VREX icon
46
PUT
Varex Imaging
VREX
$779M
$16M 0.52%
+750,000
New +$19.1M
STAA icon
47
STAAR Surgical
STAA
$1.28B
$15.7M 0.51%
196,074
+35,100
+22% +$2.61M
SRPT icon
48
CALL
Sarepta Therapeutics
SRPT
$1.94B
$15.6M 0.51%
+200,000
New +$15.3M
COO icon
49
CALL
Cooper Companies
COO
$15B
$15.6M 0.51%
+149,200
New +$15M
CCCC icon
50
C4 Therapeutics
CCCC
$474M
$15.2M 0.49%
624,860
+595,616
+2,037% +$14.5M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.